Considerations for the development of Zika virus vaccines

Vaccine. 2016 Jul 19;34(33):3711-2. doi: 10.1016/j.vaccine.2016.06.012. Epub 2016 Jun 16.

Authors

K A O Martins¹, J M Dye², S Bavari²

Affiliations

¹ United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States; Ke'Aki Technologies, 5301 Buckeystown Pike, Suite 460, Frederick, MD 21704, United States. Electronic address: karen.a.martins2.ctr@mail.mil.
² United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States.

PMID: 27318417
DOI: 10.1016/j.vaccine.2016.06.012

No abstract available

MeSH terms

Antibodies, Viral / immunology
Antigens, Viral / immunology
Biomedical Research
Female
Humans
Immunogenicity, Vaccine
Pregnancy
Pregnancy Complications, Infectious / prevention & control
Pregnancy Complications, Infectious / virology
Viral Vaccines / therapeutic use*
Zika Virus
Zika Virus Infection / prevention & control*

Substances

Antibodies, Viral
Antigens, Viral
Viral Vaccines